Connect with us
Currently, the German medical cannabis market serves a relatively small part of the population, with approximately 28,000 patients, or less than 0.03% of the German population...
NERV's recommendation is an important step towards changing the approach to cannabis in the Czech Republic. The introduction of a legal market can bring significant economic...
The Spanish legislative delay has allowed Portugal to take the lead and establish the foundations to become the productive arm of medical cannabis on the peninsula....
The legalization of cannabis in Germany opens new perspectives for responsible consumption, market regulation and protection of society, especially its younger members. By introducing clear rules...
Switzerland has the advantage that it has already introduced legalization tests in various municipalities. Each test can cover up to 5,000 people, with no limit to...
This is a challenge and an opportunity for Member States to adapt their approaches in light of these trends. These changes to cannabis policy in Europe...
The planned cannabis decriminalization by Health Minister Karl Lauterbach (SPD) is being sharply criticized from many sides. In fact, it is questionable whether the central goals...
The legalization of cannabis in Hawaii is an important step towards a modern and responsible drug policy. Hawaii's cannabis legalization bill offers a balanced approach that...
The European Cannabis Initiative highlights the importance of a human rights-focused approach to drug policy, proposing a move away from repressive control methods. It points to...
Curaleaf International, a subsidiary of Curaleaf Holdings, is Europe's largest vertically integrated cannabis company. Curaleaf has established itself as a trusted supplier of cannabis-based medicines in...